New implant tackles cataracts and glaucoma in one surgery
NCT ID NCT07154797
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a device that combines a bimatoprost implant with a special intraocular lens to treat both cataracts and glaucoma or high eye pressure. Twenty-four participants received the implant during cataract surgery. The main goals were to see if it lowers eye pressure and improves vision. Results showed it reduced eye pressure and the need for glaucoma drops.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bimatoprost implant combined with a special intraocular lens
- What this could lead to
- If it works, this could offer a one-time treatment for both cataracts and glaucoma, reducing the need for daily eye drops.
- What could go wrong
- This was a small, early study with only 24 participants and no comparison group. Long-term safety and effectiveness are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Oftalmológico Robles
Santa Rosa de Copán, 41101, Honduras
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple stress ball or favorite tune replace anxiety meds during eye surgery?
- Can a new eye test match the gold standard for glaucoma?
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?